Fundraising Fox

Concertobio

Cambridge, US · 7 known investors

concertobio.com ↗

Concerto develops microbial ecology data and AI tools to engineer microbe-based products for consumer health applications including skincare, chronic disease, and nutrition. The company generates ecological datasets and machine learning models to predict microbial community behavior and improve real-world product efficacy.

AI & Machine LearningBiotechDeep Techin /concerto-biosciences@concertobio

Founders & leadership

SL
Sarah LuppinoDirector
VS
Vera SchroederDirector
JK
Jared KeheExecutive Officer, Director
CA
Cheri AckermanExecutive Officer, Director
BC
Bernardo CervantesExecutive Officer, Director

Investors · 7

Excelestar VenturesAndover
Golden SeedsFlushing · $250K – $2M
Horizons VenturesHong Kong · $1M – $110M
ISVWest Palm Beach
MassVenturesWaltham · $250K – $500K
Axial VCreportedSan Francisco · $100K – $5M
M VenturesreportedLos Angeles · $10.8M

Reported raises · per SEC filings

Form D private placements
▶$24.5MraisedJun 2022 · 37 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sarah LuppinoDirector
  • Vera SchroederDirector
  • Jared KeheExecutive Officer, Director
  • Cheri AckermanExecutive Officer, Director
  • Bernardo CervantesExecutive Officer, Director
Offering amount
$24.5M
Amount sold
$24.5M
First sale
Mar 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.